These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 25281742)
1. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa. Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742 [TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer. Eriksson O; Thulin Å; Asplund A; Hegde G; Navani S; Siegbahn A BMC Cancer; 2016 May; 16():341. PubMed ID: 27246245 [TBL] [Abstract][Full Text] [Related]
3. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2. Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709 [TBL] [Abstract][Full Text] [Related]
4. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells. Wiiger MT; Prydz H Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840 [TBL] [Abstract][Full Text] [Related]
5. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347 [TBL] [Abstract][Full Text] [Related]
6. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling. Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902 [TBL] [Abstract][Full Text] [Related]
7. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441 [TBL] [Abstract][Full Text] [Related]
8. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Camerer E; Huang W; Coughlin SR Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786 [TBL] [Abstract][Full Text] [Related]
9. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells. Rothmeier AS; Versteeg HH; Ruf W J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873 [TBL] [Abstract][Full Text] [Related]
10. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells. Jiang X; Zhu S; Panetti TS; Bromberg ME Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells. Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200 [TBL] [Abstract][Full Text] [Related]
12. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor. Zhong D; Bajaj MS; Schmidt AE; Bajaj SP J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140 [TBL] [Abstract][Full Text] [Related]
14. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells. Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596 [TBL] [Abstract][Full Text] [Related]
15. Factor VII mutant V154G models a zymogen-like form of factor VIIa. Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603 [TBL] [Abstract][Full Text] [Related]
16. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2. Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095 [TBL] [Abstract][Full Text] [Related]
17. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates. Fiore MM; Neuenschwander PF; Morrissey JH Blood; 1992 Dec; 80(12):3127-34. PubMed ID: 1467519 [TBL] [Abstract][Full Text] [Related]
18. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972 [TBL] [Abstract][Full Text] [Related]